Actually, League....I like watching the bashers give a poorly executed tirade. Confirms my opinion of them as having no substance.
You might want to delete your post "Not sure why this was deleted." It seems to have become the site of a desultory philippic and you have the power to enjoy flushing it down the john.
Oh Terry. It's too bad you have to try and deceive people with all your cloned IDs. The only people who believe you are all your alter ego IDs. Too bad we don't have a picture of you, as we could give it to a Picture Dictionary and have it posted next to the definition of LOSER!!
Did you delete this too ? Repost of original( 5 responses also deleted ) ***.Cubist is Nothing like Insmed.***
We're just like them ! ! ..... 8 times revenues is how they valued the buyout ! !
INSM will have billions ! ...............Fact: Merck valued and bought Cubist for their pipeline.
Cubist has a rich pipeline with many drug indications, blockbuster sales, and coming approvals .
Cubist is a global leader in antibiotics and has built a strong portfolio of both marketed and late-stage pipeline medicines.
Insmed has a startup pipeline - no approvals no sales, unknowns possible failures
and yet jad9000 posted .....8 X sales = 8 Billion We're just like them !. (sic)
If this jerk ever showed up at an investors meeting ,"jad" would be laughed out the door in a NY second.
Arikayce is a possible winner- depending on the label outcome which remains to be seen and a multiyear NTM trial that awaits INSM investors in the U.S..... Sales remain an unkown.
It is one thing to be hopeful regarding Insmed future,its another to be an uninformed investor.
I finally have to agree,Terry was right Arikayce for cystic fibrosis in the US is DEAD.. I hope NTM comes through in the Phase 3 trial.
Really Jad, how funny is it that when I ask Terry to challenge, newagebios says that Terry is gone.... I don't know if my wife is at home or not but newagebios knows that terry is gone.....freak show doesn't even begin to describe this person. His obsession with kvn is a bit scary, however, reminds me of an episode of the new CBS drama Stalker....
Rook. Terry and the IDs can't supply facts, because it's not in their DNA. Terry will have to take his orders from someone else, as he is the Novartis shill on this board. Go ahead and mention IPLEX and its benefits and how they might effect Insmed in the future, we can sit back and watch the MB fireworks begin!!
Sentiment: Strong Buy
Thoughtful post from visionquest08.
I would expect in order to meet the end of year timeline the submission had to have happened at an earlier date then the 16th since the following week is the Christmas holiday. I doubt much gets done during the holiday week and Insmed should have planned around the holiday calendar. I think we should hear something by early next week. Just my guess.
Any predictions on the stock movement when the acceptance is PRed?
Sentiment: Strong Buy
And we have three different fake ids posting rom the schizo freak Terry - he's really on a freak show roll this morning. Here's the current list of fake Ids:. terry_amin/terry_insm/kim_philbee/newagebios/kvmncdd/eastofhgwy1/winkiechantwhenistudy/biotecktruth/blasedp3l/themanfromkolob/chem24_2001/killgallenkill/yousstupid. This clown is a complete whack job. Back to your rubber room Terry.
Sentiment: Strong Buy
I wished I had listened to Terry this year Just these 3 ! I am down almost 70% this year
terry_insmed • Sep 30, 2014 3
3 of my calls could have given you a 100% profit in a short period of time.
March 26 " Buy in the morning dump on misunderstood news - "Go or stay long " ( under 16) ( kvncmcdd sells I pulled the trigger!!)............great profits in a week
On April 2 downtrend starts 19.76 short ( kvncmcdd gets back in long.. )cover with the bad CF News
6/26h rebalancing and easily the best setup "short all you can " the volume allows you to buy a lot ( double top). I tell ya here comes the dilution and I cover 11.60ish. Thanks to Cathy
*** FRom a 500 million dollar opportunity to No US sales (repost)
This indication is easier to evaluate because the US market which was 400 Million of that 500M has vanished. ( bugsey? Is this bad?? )
NTM could be a big winner but suppose the Phase3 results are weak and Arikayce is approved for refractory only patients ?
I blush because I nailed the "telegraphing" that Insmed knew if the results were inferior the FDA would say No way in the USA
terry_insm • Jul 10, 2013 ****** Strategy emerging? - FDA US no longer presented.
"So were do we go with this data? " ---to Europe 2015 - Will Lewis
Just one problem with this outcome The US is where the big money is.
The company's glaring omission of the U.S FDA or possible launch may well be the company's plan going forward. Insmed declined to do a trial in the US.
You have told all of us about your excellent calls on INSM about a dozen times the last couple of days and since you are never wrong, post a pick - long or short, then I'll post a pick and we will have a little challenge.....What are you afraid of? I'm often wrong and since you never are you should easily win... Right?
Sure you are up $200. What a fantasy world you live in. You told us in recent weeks you were out! One lie after another. Poor Terry. $50 next Fall if not acqired earlier.